RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Clinical trials for RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA trials appear
Sign up with your email to follow new studies for RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising targeted therapy for recurrent brain tumors in kids and young adults
Disease control Recruiting nowThis study is testing a drug called Lutathera in people aged 4 to 39 with certain aggressive brain tumors or meningiomas that have come back or are growing. The drug delivers radiation directly to tumor cells that show up on a special PET scan. The goal is to find the safest dose…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated May 17, 2026 03:15 UTC
-
New hope for kids with rare brain tumors: adaptive trial tests drug cocktails
Disease control Recruiting nowThis study tests whether combining the drug ONC201 with other new agents can help children and young adults with diffuse midline gliomas (DMGs), including DIPG. The trial uses an adaptive design, meaning new drug combinations can be added as research evolves. About 360 participan…
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for kids with relapsed cancers: experimental drug CBL0137 enters trials
Disease control Recruiting nowThis study tests an experimental drug called CBL0137 in children and young adults (ages 1 to 21) whose solid tumors, brain tumors, or lymphoma have returned or stopped responding to standard treatments. The goal is to find the safest dose and see if the drug can shrink tumors by …
Matched conditions: RECURRENT DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1, PHASE2 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated May 13, 2026 15:58 UTC